A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
Haiping ZhangYang YangJunxin LiMin WangKonda Mani SaravananJinli WeiJustin Tze-Yang NgMd. Tofazzal HossainMaoxuan LiuHuiling ZhangXiaohu RenYi PanYin PengYi ShiXiaochun WanYingxia LiuYanjie WeiPublished in: PLoS Comput. Biol. (2020)